We are live on ! Find out more
SGI

Summit Global Investments Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.56%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+22.56%
3 Year Est. Return
+60.44%
5 Year Est. Return
+82.72%
10 Year Est. Return
AUM
$1.56B
AUM Growth
+$224M
Cap. Flow
+$107M
Cap. Flow %
6.86%
Top 10 Hldgs %
23.64%
Holding
660
New
197
Increased
199
Reduced
106
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 18.73%
2 Healthcare 12.12%
3 Financials 9.32%
4 Consumer Staples 9.11%
5 Consumer Discretionary 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCY icon
201
Mercury Insurance
MCY
$6.07B
$1.16M 0.07%
+21,788
New +$1.17M
VRNT
202
DELISTED
Verint Systems
VRNT
$1.15M 0.07%
+21,800
New +$1.05M
LMT icon
203
Lockheed Martin
LMT
$136B
$1.14M 0.07%
3,217
-1,777
-36% -$615K
AGL icon
204
Agilon Health
AGL
$1.6B
$1.14M 0.07%
1,688
+956
+131% +$582K
GIS icon
205
General Mills
GIS
$19.7B
$1.14M 0.07%
16,843
+577
+4% +$36.7K
SMMV icon
206
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$292M
$1.13M 0.07%
28,945
-41,207
-59% -$1.58M
RSG icon
207
Republic Services
RSG
$65.7B
$1.1M 0.07%
7,860
-21,438
-73% -$2.85M
BRK.B icon
208
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.09M 0.07%
3,641
+29
+0.8% +$8.31K
PRAA icon
209
PRA Group
PRAA
$755M
$1.08M 0.07%
21,600
+1,900
+10% +$84.5K
AMPH icon
210
Amphastar Pharmaceuticals
AMPH
$916M
$1.07M 0.07%
45,900
-14,600
-24% -$299K
NARI
211
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.07M 0.07%
11,700
-8,800
-43% -$754K
TTE icon
212
TotalEnergies
TTE
$190B
$1.05M 0.07%
21,140
+835
+4% +$41.6K
EQT icon
213
EQT Corp
EQT
$32.3B
$1.04M 0.07%
+47,824
New +$1M
IMXI icon
214
International Money Express
IMXI
$367M
$1.04M 0.07%
64,900
+15,300
+31% +$248K
VCSH icon
215
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$1.03M 0.07%
12,685
QNST icon
216
QuinStreet
QNST
$1.21B
$1.03M 0.07%
56,500
-15,547
-22% -$258K
BCC icon
217
Boise Cascade
BCC
$3.02B
$1.02M 0.07%
14,380
-1,300
-8% -$83.8K
SHG icon
218
Shinhan Financial Group
SHG
$35.6B
$1.02M 0.07%
32,917
+1,811
+6% +$58.1K
UNF icon
219
Unifirst Corp
UNF
$5.25B
$1.01M 0.06%
4,800
-3,800
-44% -$779K
LESL icon
220
Leslie's
LESL
$11M
$1.01M 0.06%
2,130
+1,590
+294% +$686K
PRG icon
221
PROG Holdings
PRG
$1.71B
$1M 0.06%
22,281
+1,400
+7% +$63.2K
CWT icon
222
California Water Service
CWT
$3.12B
$991K 0.06%
13,797
+4,200
+44% +$270K
MLI icon
223
Mueller Industries
MLI
$15.2B
$991K 0.06%
66,800
-19,600
-23% -$265K
WGO icon
224
Winnebago Industries
WGO
$909M
$989K 0.06%
+13,200
New +$950K
TR icon
225
Tootsie Roll Industries
TR
$2.98B
$982K 0.06%
+31,416
New +$909K

Similar funds

Summit Global Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Summit Global Investments held 660 positions worth $1.56B, up 17% from $1.33B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Summit Global Investments deployed $107M of net new capital in Q4 2021, opening 197 new positions and adding to 199 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intuit, an estimated $11.9M trimmed.

  • Summit Global Investments's largest Q4 2021 buy was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.
  • Summit Global Investments added most to Bristol-Myers Squibb in Q4 2021, an estimated $17.9M increase.
  • Summit Global Investments's biggest Q4 2021 reduction was Intuit, cutting an estimated $11.9M.
  • Summit Global Investments fully exited Regeneron Pharmaceuticals in Q4 2021, selling an estimated $11.4M.
  • Summit Global Investments's ten largest holdings make up 24% of its $1.56B portfolio in Q4 2021.
  • Summit Global Investments opened 197 new positions and closed 124 in Q4 2021.
  • Summit Global Investments's portfolio value rose 17% quarter-over-quarter to $1.56B.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.